This was first appreciated when recurrent inactivation of SMARCB1 (also known as INI-1 and BAF47, and encoded by SMARCB1), were discovered in malignant rhabdoid tumor, an aggressive sarcoma of childhood [58]. This evidence concerns the gene SMARCB1 and rhabdoid tumor.